-
-
-
-
-
-
-
Mineralys Therapeutics, Inc. (MLYS) PT Lowered to $30 at Jefferies
-
-
-
-
-
-
-
Mineralys Therapeutics, Inc. (MLYS) Tops Q3 EPS by 44c
-
-
-
-
-
-
-
Mineralys Therapeutics (MLYS) announces positive results from Phase 3 Launch-HTN trial
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)
-
-
-
-
-
-
-
Mineralys Therapeutics (MLYS) to Announce Topline Data from Launch-HTN and Advance-HTN Pivotal Trials Monday, March 10, 2025, at 8:00 AM ET
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)
-
-
-
446,711 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

